Date |
Research Question / Title |
Unique ID |
Research Team |
June 20, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v002 RR
|
Epidemiology & Modelling
|
June 6, 2022
|
What is known about hybrid immunity to COVID-19?
|
INF220501 RR
|
Infectious Disease
|
March 31, 2022
|
What is the incidence and duration of long COVID cases?
|
EPM210601v2 RR
|
Epidemiology & Modelling
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR
|
EOC
|
January 12, 2022
|
In real world settings, what is the validity of Rapid Antigen Tests (RATs) in identifying SARS-CoV-2 and how well do they predict disease?
|
EOC211201 RR
|
EOC
|
December 26, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v019 RR
|
Infectious Disease
|
December 22, 2021
|
What is the epidemiology of the Omicron variant and its impact on health care?
|
EOC211220 RR
|
EOC
|
December 20, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v019 RR
|
EOC
|
October 29, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901v2 RR
|
EOC
|
February 27, 2021
|
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
|
CC011101 RR
|
Critical Care
|
January 22, 2021
|
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
|
EOC062201v2 RR
|
EOC
|
December 17, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501 RR
|
Infectious Disease
|
December 9, 2020
|
What are the predictors of mortality in hospitalized COVID-19 patients?
|
CC120402 RR
|
Critical Care
|
November 2, 2020
|
What is the risk of reinfection from COVID-19? [Update]
|
EOC032401v3 RR
|
EOC
|
September 29, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401 RR
|
EOC
|
July 27, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001 RR
|
EOC
|
May 19, 2020
|
What are the risk factors for severity and death associated with COVID-19?
|
EPM050901 RR
|
Epidemiology & Modelling
|
May 19, 2020
|
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
|
LAB041601v2 RR
|
Laboratory
|
May 11, 2020
|
What percentage of COVID-19 patients have hyposmia or anosmia?
|
EOC033102 RR
|
EOC
|
May 8, 2020
|
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
|
LAB040701v2 RR
|
Laboratory
|